Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
- PMID: 26201801
- DOI: 10.1007/s12072-012-9392-1
Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
Abstract
Purpose: Diffuse infiltrative hepatocellular carcinoma (D-HCC) is an incurable disease with short survival time. Transarterial chemoembolization (TACE) was often used to alleviate patient's symptoms and reduce tumor burden. However, it remains unknown if the TACE benefits the survival of D-HCC patients.
Methods: A hospital-based retrospective study was conducted at a large referral hospital in Taiwan for a 9-year period (2000-2008).
Results: Of the 150 D-HCC patients, 106 patients were related to hepatitis B virus (HBV), 17 to hepatitis C virus (HCV), 3 to both HBV and HCV, and 24 not to HBV or HCV. Multivariate Cox regression analysis showed treatment strategy, serum alpha-fetoprotein level, model for end-stage liver disease (MELD) score, serum gamma glutamyl transferase, and serum lactic acid dehydrogenase were associated with survival time. Compared to supportive treatment, the adjusted hazard ratios of transarterial chemoembolization (TACE) and chemotherapy including oral or systemic chemotherapy were 0.383 (p < 0.001) and 0.711 (p = 0.289), respectively.
Conclusion: TACE is a preferred therapy for D-HCC patients.
Keywords: Diffuse infiltrative type; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Transarterial chemoembolization.
Similar articles
-
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z. World J Surg Oncol. 2016. PMID: 27038790 Free PMC article.
-
Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.Cytokine. 2015 Dec;76(2):449-457. doi: 10.1016/j.cyto.2015.07.001. Epub 2015 Jul 8. Cytokine. 2015. PMID: 26163999
-
Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13. Liver Int. 2014. PMID: 24028297
-
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327. World J Gastroenterol. 2015. PMID: 26420959 Free PMC article. Review.
-
Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.Drug Des Devel Ther. 2015 Aug 10;9:4431-40. doi: 10.2147/DDDT.S86629. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26309396 Free PMC article. Review.
Cited by
-
Age and clinical spectrum of COVID-19 are associated with safety of transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study.J Gastrointest Oncol. 2024 Dec 31;15(6):2642-2655. doi: 10.21037/jgo-24-527. Epub 2024 Dec 28. J Gastrointest Oncol. 2024. PMID: 39816043 Free PMC article.
-
Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.BMC Cancer. 2019 Nov 29;19(1):1162. doi: 10.1186/s12885-019-6386-6. BMC Cancer. 2019. PMID: 31783814 Free PMC article.
-
Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study.J Hepatocell Carcinoma. 2024 Sep 9;11:1727-1740. doi: 10.2147/JHC.S477872. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39281003 Free PMC article.
-
High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma.Ann Transl Med. 2021 Jan;9(1):17. doi: 10.21037/atm-20-1616. Ann Transl Med. 2021. PMID: 33553310 Free PMC article.
-
A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.J Gastrointest Oncol. 2022 Feb;13(1):298-310. doi: 10.21037/jgo-21-450. J Gastrointest Oncol. 2022. PMID: 35284131 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous